NCT03508115
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +10 more
- Locations
-
Not specified
Clinical trial condition
Hepatitis
Explore clinical trials studying Hepatitis. Study availability and eligibility vary by location and protocol.
2,969 public trials
189 recruiting studies
Hepatitis trial results
NCT01037114
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +12 more
- Locations
-
- GSK Investigational Site Ghent, Belgium
NCT02548325
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- Mútua de Terrassa Terrassa, Barcelona, Spain
NCT00071916
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
- Locations
-
- University of Arkansas Little Rock, Arkansas, United States
- University of Tennessee Memphis, Tennessee, United States
- Vanderbilt University Nashville, Tennessee, United States
Completed
Hepatitis B Vaccine for Non-responders
NCT03415672
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- Vaxinfectio - Antwerp University Antwerp, Belgium
- Ziekenhuis Oost-Limburg Genk, Belgium
- Maastricht UMC Maastricht, Netherlands
NCT02003703
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +9 more
- Locations
-
- Hospital Gustavo Fricke Viña del Mar, Valparaiso, Chile
NCT02251990
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
- Locations
-
Not specified
Completed
Treatment Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in naïve Chronic Hepatitis B
NCT02533544
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
- Locations
-
- The Catholic University of Korea, Daejeon St.Mary's Hosptial Junggu, Daejeon, South Korea
NCT02807402
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
- Locations
-
Not specified
Completed
Evaluation of MK-1075 in Participants With Hepatitis C Virus (HCV) Infection (MK-1075-002)
NCT02392494
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
- Locations
-
Not specified